- £784.34m
- £782.91m
- $174.02m
- 97
- 18
- 94
- 83
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 71.4 | 71.5 | 75.6 | 166 | 174 |
Cost of Revenue | |||||
Gross Profit | 67 | 67 | 70.2 | 142 | 148 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 53.4 | 52.3 | 62.3 | 147 | 155 |
Operating Profit | 18 | 19.2 | 13.2 | 18.1 | 19.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.3 | 19.3 | 13.2 | 13.1 | 13.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15 | 16.8 | 12.9 | 9.41 | 9.23 |
Net Income Before Extraordinary Items | |||||
Net Income | 15 | 16.8 | 12.9 | 9.41 | 9.23 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15 | 16.8 | 12.9 | 9.41 | 9.23 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.585 | 0.619 | 0.726 | 0.317 | 0.23 |
Dividends per Share |